Molecular Characteristics of Response to Olutasidenib (FT-2102) in Patients with Relapsed/Refractory mIDH1 Acute Myeloid Leukemia

被引：2

作者：

De Botton, Stephane ^{[1
]}

Yee, Karen ^{[2
]}

Recher, Christian ^{[3
]}

Wei, Andrew H. ^{[4
]}

Montesinos, Pau ^{[5
]}

Taussig, David ^{[6
]}

Pigneux, Arnaud ^{[7
]}

Braun, Thorsten ^{[8
]}

Curti, Antonio ^{[9
]}

Esteve, Jordi ^{[10
]}

Grove, Carolyn ^{[11
]}

Jonas, Brian A. ^{[12
]}

Khwaja, Asim ^{[13
,14
]}

Legrand, Olivier ^{[15
]}

Peterlin, Pierre ^{[16
]}

Sangerman, Montserrat Arnan ^{[17
]}

Blum, William G. ^{[18
]}

Cilloni, Daniela ^{[19
]}

Hiwase, Devendra ^{[20
]}

Jurcic, Joseph G. ^{[21
]}

Krauter, Jurgen ^{[22
]}

Thomas, Xavier ^{[23
]}

Watts, Justin ^{[24
]}

Yang, Jay ^{[25
]}

Xin, Zihao ^{[26
]}

Sedkov, Alex ^{[26
]}

Guichard, Sylvie ^{[26
]}

Sweeney, Jennifer ^{[26
]}

Marzac, Christophe ^{[27
]}

Cortes, Jorge E. ^{[28
]}

Fenaux, Pierre ^{[29
]}

机构：

[1] Inst Gustave Roussy, Dept Haematol, Villejuif, France

[2] Princess Margaret Canc Ctr, Toronto, ON, Canada

[3] Inst Univ Canc Toulouse Oncopole, Paris, France

[4] Alfred Hosp, Dept Haematol, Melbourne, Australia

[5] Hosp Univ Politecn La Fe Valencia, Dept Hematol, Valencia, Spain

[6] Royal Marsden NHS Fdn Trust, Sutton, Surrey, England

[7] Univ Bordeaux, Dept Hematol, Ctr HospUniv CHU Bordeaux, Bordeaux, France

[8] Paris XIII Univ, Hop Avicenne, AP HP, Bobigny, France

[9] IRCCS Azienda Osped Univ Bologna, Ist Ematol Seragnoli, Bologna, Italy

[10] Hosp Clin Barcelona, Dept Hematol, Barcelona, Spain

[11] PathWest Sir Charles Gairdner Hosp, Dept Haematol, Dept Hlth, Nedlands, WA, Australia

[12] Univ Calif Davis, Div Hematol & Oncol, Dept Internal Med, Davis, CA USA

[13] Univ Coll London Hosp, London, England

[14] Univ Coll Canc Inst, London, England

[15] St Antoine Univ Hosp, Dept Hematol, Paris, France

[16] CHU Nantes, Serv Hematol Clin, Nantes, France

[17] IDIBELL, Inst Catala Oncol, Hosp Duran & Reynals, Clin Hematol Dept, Barcelona, Spain

[18] Emory Univ, Winship Canc Inst, Atlanta, GA USA

[19] Univ Turin, Dept Clin & Biol Sci, Turin, Italy

[20] Royal Adelaide Hosp, Dept Haematol, Adelaide, SA, Australia

[21] Columbia Univ, Herbert Irving Comprehens Canc Ctr, Med Ctr, New York, NY USA

[22] Braunschweig Municipal Hosp, Dept Internal Med 3, Braunschweig, Germany

[23] Lyon Sud Univ Hosp, Hosp Civils Lyon, Dept Hematol, Pierre Benite, France

[24] Univ Miami, Dept Med, Leukemia Program, Sylvester Comprehens Canc Ctr, Miami, FL USA

[25] Karmanos Canc Inst, Dept Oncol, Detroit, MI USA

[26] Forma Therapeut Inc, Watertown, MA USA

[27] Univ Paris Saclay, Dept Biol pathol, Gustave Roussy, Villejuif, France

[28] Georgia Canc Ctr, Augusta, GA USA

[29] St Louis Hosp, Dept Haematol, Paris, France

来源：

BLOOD | 2021年 / 138卷

关键词：

D O I：

10.1182/blood-2021-144912

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

2351

引用

页数：9

共 50 条

[31] Association of Genetic Characteristics with Response to Venetoclax Plus Hypomethylating Agents in Relapsed and Refractory Acute Myeloid Leukemia
Weng, Guangyang
Zhang, Yu
Yu, Guopan
Xu, Na
Sun, Zhiqiang
Lin, Dongjun
Liang, Xinquan
Deng, Lan
Xiao, Jie
Zhang, Hongyu
Guo, Ziwen
Jin, Hua
Du, Xin
Liu, Qifa
BLOOD, 2022, 140 : 2025 - 2026
[32] Molecular Predictors of Response and Survival in Patients with Relapsed/Refractory Acute Myeloid Leukemia Following Venetoclax Plus Hypomethylating Agent Therapy
Johnson, Isla McKerrow
Ilyas, Rimal
McCullough, Kristen
Al-Kali, Aref
Alkhateeb, Hassan B.
Begna, Kebede
Mangaonkar, Abhishek A.
Litzow, Mark R.
Hogan, William J.
Shah, Mithun, V
Patnaik, Mrinal M.
Pardanani, Animesh
Tefferi, Ayalew
Gangat, Naseema
BLOOD, 2022, 140 : 3233 - 3234
[33] Association of leukemia genetics with response to venetoclax and hypomethylating agents in relapsed/refractory acute myeloid leukemia
Aldoss, Ibrahim
Yang, Dongyun
Pillai, Raju
Sanchez, James F.
Mei, Matthew
Aribi, Ahmed
Ali, Haris
Sandhu, Karamjeet
Al Malki, Monzr M.
Salhotra, Amandeep
Khaled, Samer
Sun, Weili
O'Donnell, Margaret
Snyder, David
Nakamura, Ryotaro
Stein, Anthony S.
Forman, Stephen J.
Marcucci, Guido
Pullarkat, Vinod
AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (10) : E253 - E255
[34] Azacitidine combined with gemtuzumab ozogamicin in patients with relapsed/refractory acute myeloid leukemia
Bayraktar, Ulas Darda
Domingo, Gelenis Calzadilla
Schmit, Jessica
Pereira, Denise
LEUKEMIA & LYMPHOMA, 2011, 52 (05) : 913 - 915
[35] NATIONAL EXPERIENCE WITH THE USE OF VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY ACUTE MYELOID LEUKEMIA
Labrador, J.
Saiz-Rodriguez, M.
De Miguel, D.
Vidriales, M. B.
Perez-Encinas, M.
Sanchez-Sanchez, M. J.
Cuello, R.
Roldan-Perez, A.
Vives, S.
Benzo-Callejo, G.
Colorado, M.
Garcia-Fortes, M.
Sayas, M. J.
Olivier, C.
Recio, I
Seri-Merino, C.
Tormo, M.
Vall-llovera, F.
Foncillas, M. A.
Montesinos, P.
HAEMATOLOGICA, 2020, 105 : 56 - 56
[36] A phase II study of bisantrene in patients with relapsed/refractory acute myeloid leukemia
Canaani, Jonathan
Danylesko, Ivetta
Shemtov, Noga
Zlotnick, Maya
Lozinsky, Kira
Benjamini, Ohad
Yerushalmi, Ronit
Nagar, Meital
Dor, Chen
Shimoni, Avichai
Avigdor, Abraham
Nagler, Arnon
EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 106 (02) : 260 - 266
[37] Infections in children with acute myeloid leukemia: increased mortality in relapsed/refractory patients
Zajac-Spychala, Olga
Skalska-Sadowska, Jolanta
Wachowiak, Jacek
Szmydki-Baran, Anna
Hutnik, Lukasz
Matysiak, Michal
Pierlejewski, Filip
Mlynarski, Wojciech
Czyzewski, Krzysztof
Dziedzic, Magdalena
Wysocki, Mariusz
Zalas-Wiecek, Patrycja
Bartnik, Magdalena
Ociepa, Tomasz
Urasinski, Tomasz
Malas, Zofia
Badowska, Wanda
Gamrot-Pyka, Zuzanna
Woszczyk, Mariola
Tomaszewska, Renata
Szczepanski, Tomasz
Irga-Jaworska, Nina
Drozynska, Elzbieta
Urbanek-Dadela, Agnieszka
Karolczyk, Grazyna
Plonowski, Marcin
Krawczuk-Rybak, Maryna
Fraczkiewicz, Jowita
Salamonowicz, Malgorzata
Chybicka, Alicja
Stolpa, Weronika
Sobol-Milejska, Grazyna
Chelmecka-Wiktorczyk, Liliana
Balwierz, Walentyna
Zak, Iwona
Gryniewicz-Kwiatkowska, Olga
Gietka, Aneta
Dembowska-Baginska, Bozenna
Semczuk, Katarzyna
Dzierzanowska-Fangrat, Katarzyna
Musial, Jakub
Chaber, Radoslaw
Kowalczyk, Jerzy
Styczynski, Jan
LEUKEMIA & LYMPHOMA, 2019, 60 (12) : 3028 - 3035
[38] A Phase II Study of Bisantrene in Patients with Relapsed/Refractory Acute Myeloid Leukemia
Canaani, Jonathan
Danilesko, Ivetta
Shem-Tov, Noga
Zlotnick, Maya
Lozinsky, Kira
Benjamini, Ohad
Yerushalmi, Ronit
Nagar, Meital
Dor, Chen
Shimoni, Avichai
Avigdor, Abraham
Nagler, Arnon
BLOOD, 2020, 136
[39] Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.
Smith, Catherine Choy
Levis, Mark J.
Litzow, Mark Robert
Perl, Alexander E.
Altman, Jessica K.
Gill, Stan
Yuen, Geoffrey
Bonate, Peter
Kadokura, Takeshi
James, Angela Joubert
Liu, Charles
Nagase, Itsuro
Fisniku, Ogert
Bahceci, Erkut
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[40] Concentration–QTc analysis of quizartinib in patients with relapsed/refractory acute myeloid leukemia
Dongwoo Kang
Elizabeth Ludwig
David Jaworowicz
Hannah Huang
Jill Fiedler-Kelly
Jorge Cortes
Siddhartha Ganguly
Samer Khaled
Alwin Krämer
Mark Levis
Giovanni Martinelli
Alexander Perl
Nigel Russell
Malaz Abutarif
Youngsook Choi
Ophelia Yin
Cancer Chemotherapy and Pharmacology, 2021, 87 : 513 - 523

← 1 2 3 4 5 →